Clinical Trial Update: Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) [Phase 1]

View source ↗

Summary

Phase 1 trial update for ANA773 in healthy volunteers and hepatitis C patients assessing safety, tolerability, pharmacokinetics and pharmacodynamics. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• ANA773

Snippet

Sponsor: Hoffmann-La Roche | Conditions: HCV Infection | Phase 1 | Status: COMPLETED